Cargando…

A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis

Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (Mtb) and is a major cause of morbidity and mortality. Successful treatment requires strict adherence to drug regimens for prolonged periods of time. Long-acting (LA) delivery systems have the potential to improve adher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Manse, Johnson, Claire E., Schmalstig, Alan A., Annis, Ayano, Wessel, Sarah E., Van Horn, Brian, Schauer, Amanda, Exner, Agata A., Stout, Jason E., Wahl, Angela, Braunstein, Miriam, Victor Garcia, J., Kovarova, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360445/ https://www.ncbi.nlm.nih.gov/pubmed/35941109 http://dx.doi.org/10.1038/s41467-022-32043-3

Ejemplares similares

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease
por: Dick, Thomas
Publicado: (2020)

Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Jing, Wei, et al.
Publicado: (2017)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
por: Li, Ma-Chao, et al.
Publicado: (2022)

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy
por: Chang, Yong S., et al.
Publicado: (2023)

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy
por: Chang, Yong S., et al.
Publicado: (2023)

Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
por: Pryjma, Mark, et al.
Publicado: (2018)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Sharma, Sandeep, et al.
Publicado: (2017)

Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
por: Moultrie, Harry, et al.
Publicado: (2015)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency
por: Anthony, Richard M, et al.
Publicado: (2005)

A rare case of pulmonary mycobacteriosis caused by rifabutin resistant Mycobacterium celatum and review of the literature
por: Doktorova Demmin, Marcela, et al.
Publicado: (2019)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
por: Magee, Kevin P., et al.
Publicado: (1996)

Comparison of Compartmental and Non-Compartmental Analysis to Detect Biopharmaceutical Similarity of Intravenous Nanomaterial-Based Rifabutin Formulations
por: Osipova, Nadezhda, et al.
Publicado: (2023)

Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental Mycobacterium avium infection in mice
por: Grewal, Tapinder Kaur, et al.
Publicado: (2018)

In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
por: Trebosc, Vincent, et al.
Publicado: (2020)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?
por: Rockwood, Neesha, et al.
Publicado: (2019)

Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin
por: Alnewais, Marwah E., et al.
Publicado: (2023)

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa
por: Rukasha, Ivy, et al.
Publicado: (2016)

Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia
por: Sarkar, Trina, et al.
Publicado: (2020)

Cost-Effectiveness of Vonoprazan- and Rifabutin-Based Regimens
por: Almenoff, June
Publicado: (2023)

Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41
por: Aziz, Dinah Binte, et al.
Publicado: (2020)

Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in Kurdistan treated with an antibiotic combination including Imipenem-Relebactam and Rifabutin
por: Beech, Alison J., et al.
Publicado: (2023)

Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
por: Yu, Ming-Chih, et al.
Publicado: (2022)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir
por: Cheng, Wen-Hsin, et al.
Publicado: (2015)

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020)

Comments regarding use of rifabutin for Helicobacter pylori eradication
por: Graham, David Y.
Publicado: (2021)

Effect of Rifabutin in Dolutegravir Dosing: A Case Series
por: Mendoza, Maria A., et al.
Publicado: (2022)

The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation
por: Zulauf, Katelyn E., et al.
Publicado: (2018)

1360. Disseminated Mycobacterium abscessus Infections in Patients with Neutralizing Anti-interferon-gamma Autoantibodies Treated with Rifabutin-based Combination Regimens
por: Cheng, Aristine, et al.
Publicado: (2019)

Recurrent neutropenia induced by rifabutin in a renal transplant recipient
por: Chang, Ji Yeun, et al.
Publicado: (2014)

Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series
por: Doub, James B., et al.
Publicado: (2020)

Rifabutin-Cobicistat Drug Interaction Resulting in Severe Bilateral Panuveitis
por: Toomey, Christopher B., et al.
Publicado: (2020)

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
por: Monk, Miranda, et al.
Publicado: (2022)

Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties
por: Borraccino, Antonia Valeria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pvag96f15h3g2367iavgeed6l